Better manufacturing practice for cell therapies

---

Kevin Murray

Biospherix Ltd., USA

: J Regen Med

Abstract

---

The Xvivo GMP platform reduces risk and provides superior process control for the culture, processing, and expansion of cell-based therapeutics. Total isolation protects the cells from possible contamination, the people from viral vectors, prions, as well as allow for the optimization of the cell environment. Critical cell environmental factors such as temperature, RH, CO2 and O2 can be controlled, monitored and uninterrupted throughout the entire cell production process. Dynamic incubation options allow for adjustments in incubation conditions which keep up with the changing needs of dynamic cell cultures. Superior process control results in a higher quality cell product and more consistent results for your entire protocol.

Biography

---

Kevin Murray is currently working for VP Global Sales for Biospherix, Ltd. He has completed BS Biochemistry, MBA Finance & Marketing degrees. He has more than twenty years of experience in the Pharmaceutical/Biotech/Medical Research Industry. Email: kmurray@biospherix.com